Association between Intermittent Hypoxemia and Severe Bronchopulmonary Dysplasia in Preterm Infants
- PMID: 34428130
- PMCID: PMC8759313
- DOI: 10.1164/rccm.202105-1150OC
Association between Intermittent Hypoxemia and Severe Bronchopulmonary Dysplasia in Preterm Infants
Abstract
Rationale: Bronchopulmonary dysplasia increases the risk of disability in extremely preterm infants. Although the pathophysiology remains uncertain, prior exposure to intermittent hypoxemia may play a role in this relationship. Objectives: To determine the association between prolonged episodes of intermittent hypoxemia and severe bronchopulmonary dysplasia. Methods: A post hoc analysis of extremely preterm infants in the Canadian Oxygen Trial who survived to 36 weeks' postmenstrual age was performed. Oxygen saturations <80% for ⩾1 minute and the proportion of time per day with hypoxemia were quantified using continuous pulse oximetry data that had been sampled every 10 seconds from within 24 hours of birth until 36 weeks' postmenstrual age. The study outcome was severe bronchopulmonary dysplasia as defined in the 2001 NIH Workshop Summary. Measurements and Main Results: Of 1,018 infants, 332 (32.6%) developed severe bronchopulmonary dysplasia. The median number of hypoxemic episodes ranged from 0.8/day (interquartile range, 0.2-1.1) to 60.2/day (interquartile range, 51.4-70.3) among the least and most affected 10% of infants. Compared with the lowest decile of exposure to hypoxemic episodes, the adjusted relative risk of severe bronchopulmonary dysplasia increased progressively from 1.72 (95% confidence interval, 1.55-1.90) at the 2nd decile to 20.40 (95% confidence interval, 12.88-32.32) at the 10th decile. Similar risk gradients were observed for time in hypoxemia. Significant differences in the rates of hypoxemia between infants with and without severe bronchopulmonary dysplasia emerged within the first week after birth. Conclusions: Prolonged intermittent hypoxemia beginning in the first week after birth was associated with an increased risk of developing severe bronchopulmonary dysplasia among extremely preterm infants. Clinical trial registered with www.isrctn.com (ISRCTN62491227) and www.clinicaltrials.gov (NCT00637169).
Keywords: bronchopulmonary dysplasia; extremely preterm infant; intermittent hypoxemia; pulse oximetry.
Figures


Comment in
-
Intermittent Hypoxemia and Bronchopulmonary Dysplasia: Manifestations of Immature Respiratory Control and the Preterm Lung.Am J Respir Crit Care Med. 2021 Nov 15;204(10):1126-1127. doi: 10.1164/rccm.202109-2077ED. Am J Respir Crit Care Med. 2021. PMID: 34634221 Free PMC article. No abstract available.
References
-
- Horbar JD, Carpenter JH, Badger GJ, Kenny MJ, Soll RF, Morrow KA, et al. Mortality and neonatal morbidity among infants 501 to 1500 grams from 2000 to 2009. Pediatrics . 2012;129:1019–1026. - PubMed
-
- Schmidt B, Asztalos EV, Roberts RS, Robertson CM, Sauve RS, Whitfield MF. Trial of Indomethacin Prophylaxis in Preterms (TIPP) Investigators. Impact of bronchopulmonary dysplasia, brain injury, and severe retinopathy on the outcome of extremely low-birth-weight infants at 18 months: results from the trial of indomethacin prophylaxis in preterms. JAMA . 2003;289:1124–1129. - PubMed
-
- Jensen EA, Dysart K, Gantz MG, McDonald S, Bamat NA, Keszler M, et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. The diagnosis of bronchopulmonary dysplasia in very preterm infants: an evidence-based approach. Am J Respir Crit Care Med . 2019;200:751–759. - PMC - PubMed
Publication types
MeSH terms
Supplementary concepts
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Medical